spacer
home > pmps > autumn 2008 > clinical certainty
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Clinical Certainty

Four years after establishing our own clinical manufacturing business, it is more apparent than ever, both to us and to others in the industry, that the sector is in a constant state of development and innovation. New technologies, changing market conditions and an increasingly rigid regulatory regime have all combined to present both challenges and opportunities. No single development or circumstance stands out as the key catalyst for change; there are a whole range of factors that can make the difference between success and failure for an expanding small or medium clinical manufacturing company.

GROWTH

The first issue for any business is the pursuit of growth and how this goal is to be managed and achieved. The market exists, but it is vital that a planned expansion strategy is put into place and then followed. Part of the reason for this is to protect standards, whether stipulated by a regulator or demanded by a client, which must then be met.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
With more than 30 years’ experience in quality assurance, manufacturing and research and development, Brian Dougherty has a breadth of expertise across the pharmaceutical sector. A registered pharmacist, achieving QP status in 1983, he set up SCM Pharma Ltd in 2004 with business partner Fiona Cruickshank. Brian is Chair of the Association of Specials Manufacturers (ACSM), a member of the Chartered Institute of Directors and an elected member of the Industrial Pharmacist Group (of the Royal Pharmaceutical Society).
spacer
Brian Dougherty
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

MedPharm’s CSO and University of Reading Professor co-author new book on dermal formulation development

MedPharm’s Chief Scientific Officer and Co-Founder, Professor Marc Brown and University of Reading’s Professor Adrian Williams have co-authored the new book: ‘The Art and Science of Dermal Formulation Development”. It is the latest addition to ‘Drugs and the Pharmaceutical Sciences’, a series of textbooks and monographs published by CRC Press.
More info >>

White Papers

Exploring Protein Stability by nanoDSF

NanoTemper Technologies GmbH

nanoDSF determines thermal and chemical protein stability with ultra-high resolution and with unmatched reproducibility. The detection of the intrinsic tryptophan and tyrosin fluorescence enables measurements at close-to-native conditions in any buffer, even in the presence of detergents. nanoDSF is applied in antibody engineering, membrane protein research, formulation and quality control.
More info >>

 
Industry Events

SAPHEX 2019

23-24 October 2019, GALLAGHER CONVENTION CENTRE, 10 RICHARDS DRIVE, HALFWAY HOUSE, MIDRAND, 1685, SOUTH AFRICA

SAPHEX 2019 will be held on the 23rd-24th October at the Gallagher Convention Centre, Johannesburg, South Africa.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement